Latest News

About 35,000 people die from drug-resistant infection in the US. What are we going to do?
When antibiotics first achieved widescale use in the middle of the 20th century, they had a tremendous impact. For example, the mortality rate in England from infectious disease dropped from 25% in 1…
Read more
Nasal nanoSTING vaccines may Provide Lasting Protection Against SARS-CoV-2
All successful vaccines against SARS-CoV-2 have used the spike protein as the target and delivered the vaccine by intramuscular injection, typically a shot in the left or right shoulder. The vaccines…
Read more
Probiotic Bacterium can prevent antibiotic use side effects
Researchers at the University of Maryland School of Medicine demonstrate the power of probiotics. A test group was given Bifidobacterium lactis BB-12 as they took a course of amoxicillin clavula…
Read more
The CDC publishes another study that shows the protection that vaccination provides against COVID-19
The CDC is out with another recent study comparing the incidence rate of COVID-19 in unvaccinated vs. vaccinated individuals. It is mostly good news. The vaccine protects against infection, hospitali…
Read more
No, that is NOT what the study says -- Immunity to COVID
I am getting tired of the scare tactics that news and media sources are using to get you to click on headlines. Headlines in some press releases drive me bananas: New study: Nursing home residents,…
Read more


Huge positive news on the effort to create a coronavirus vaccine


Pfizer has announced early data in its vaccine trial that indicates an efficacy of 90%! The news could not be better. While the article claims this is early data if you dig down into the details they indicate how many subjects were infected with coronavirus during the study. When the analysis was done, 94 people had been infected. To complete the trial, scientists decided that 164 need to be infected. We are already halfway there. This is the last piece of the puzzle and means we will have an effective vaccine. One caveat is that the Pfizer vaccine is an RNA vaccine. While this makes it easy to manufacture, the vaccine needs to be stored at very low temperatures. Thus transport of the vaccine for distribution will be an issue.

Several other vaccines are in the pipeline and I expect their results to be just as good. Hurray for science.